Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Adaptive blood pressure-modulated atrial pacing in hypertensive HFpEF patients: a randomized, first-in-human study1 passage
• Anaemia and all-cause mortality in contemporary heart failure with preserved ejection fraction (left ventricular ejection fraction ≥50%): an updated systematic review and meta-analysis1 passage
• Assessing cardiovascular benefits of intensive blood pressure lowering in high-risk undiagnosed HFpEF patients1 passage
• Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction1 passage
• Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial1 passage
• Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis1 passage
• Cilostazol in patients with heart failure and preserved ejection fraction-The CLIP-HFpEF trial1 passage
• Circulating dipeptidyl peptidase 3 and outcomes in acute heart failure: an analysis of the STRONG-HF and CORTAHF studies1 passage
• Comparative analysis of randomized versus real-world populations in heart failure: DIAMOND trial vs CARE-HK registry1 passage
• Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis1 passage
• Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis1 passage
• Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study1 passage
• Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure1 passage
• Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis1 passage
• HEART Camp Connect-Promoting adherence to exercise in adults with heart failure with preserved ejection fraction1 passage
• High vs. low oxygen therapy in patients with acute heart failure: HiLo-HF pilot trial1 passage
• Highlights in heart failure1 passage
• Kidney tubule injury is associated with sodium avidity and diuretic responsiveness in acute heart failure1 passage
• Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial1 passage
• Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN1 passage
• Long-term mortality in heart failure with mid-range ejection fraction: systematic review and meta-analysis1 passage
• Lower limb compression in acute heart failure and predominant tissue congestion: rationale and design of the COMPRESSION-HF trial1 passage
• Mortality and heart failure hospitalizations in heart failure with preserved ejection fraction compared to heart failure with reduced ejection fraction: a systematic review and meta-analysis25 passages
• Outpatient treatment of decompensated heart failure: A systematic review and study level meta-analysis1 passage
• Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature1 passage
• Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials1 passage
• Predictive value of NT pro BNP for new-onset atrial fibrillation in heart failure and preserved ejection fraction1 passage
• Prevalence and characteristics of upfront diuretic resistance in acute heart failure: The P-Value-AHF study1 passage
• Prevalence of cardiac amyloidosis in screening studies: a systematic review and meta-analysis1 passage
• Prognostic models for patients suffering a heart failure with a preserved ejection fraction: a systematic review1 passage
• Prognostic performance of cardiogenic shock 4 proteins prediction model in infarct-related cardiogenic shock1 passage
• Pulmonary congestion relief by adding dapagliflozin to intravenous loop diuretic in acute heart failure patients1 passage
• Randomized double-blind clinical studies of ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta-analysis1 passage
• Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure1 passage
• Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF1 passage
• Recovery free of heart failure after acute coronary syndrome and coronary revascularization1 passage
• Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis1 passage
• Risk of in-hospital life-threatening ventricular arrhythmia or death after ST-elevation myocardial infarction vs. the Takotsubo syndrome1 passage
• Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis1 passage
• Safety and efficacy of adaptive atrial pacing regulated by blood pressure during low-level exercise: a proof-of-concept study1 passage
• Safety and efficacy of early initiation of mineralocorticoid receptor antagonist after an acute decompensated heart failure event or acute myocardial infarction with cardiac dysfunction: a meta-analysis of randomized clinical trials1 passage
• Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study1 passage
• Sodium-glucose cotransporter-2 inhibitors in heart failure: an updated meta-analysis1 passage
• Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study1 passage
• The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure1 passage
• The prognosis of mid-range ejection fraction heart failure: a systematic review and meta-analysis1 passage
• The role of intra-abdominal pressure and point of care ultrasound to guide decongestive therapies in acute heart failure1 passage
• Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF)1 passage
• Training-induced change of diastolic function in heart failure with preserved ejection fraction1 passage
• Variation in clinical and patient-reported outcomes among complex heart failure with preserved ejection fraction phenotypes1 passage
• Veno-Arterial Extracorporeal Life Support in Heart Transplant and Ventricle Assist Device Centres. Meta-analysis1 passage